GSK drops com­mer­cial du­ties in Kenya, shifts to dis­trib­u­tor mod­el

GSK is shut­ter­ing com­mer­cial op­er­a­tions in Kenya and tap­ping third par­ties to take over dis­tri­b­u­tion, the com­pa­ny said on Thurs­day morn­ing.

The move, re­port­ed ear­li­er by Busi­ness Dai­ly Africa, will im­pact a num­ber of jobs, though GSK has de­clined to re­veal how many. With the spin­out of Ha­le­on this sum­mer, GSK no longer owns any man­u­fac­tur­ing sites in Kenya.

“We will con­tin­ue to sup­ply our need­ed med­i­cines and vac­cines in Kenya, and we will work with our dis­tri­b­u­tion part­ners to­wards a smooth tran­si­tion in 2023,” a GSK spokesper­son said in an email to End­points News. 

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER